Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma

被引：81

作者：

Ludwig, Heinz ^{[1
]}

Drach, Johannes ^{[2
]}

Graf, Helmut ^{[3
]}

Lang, Alois ^{[4
]}

Meran, Johannes Gobertus ^{[5
]}

机构：

[1] Wilhelminenspital Stadt Wien, Dept Med 1, Ctr Oncol & Hematol, Montleartstr 37, A-1170 Vienna, Austria

[2] Univ Hosp, Dept Internal Med 1, Div Oncol, Vienna, Austria

[3] Krankenanstalt Rudolfstiftung Wien, Internal Dept 3, Vienna, Austria

[4] LKH Feldkirch, Dept Internal Med, Feldkirch, Austria

[5] Krankenhaus Barmherzigen Brueder, Vienna, Austria

来源：

HAEMATOLOGICA | 2007年 / 92卷 / 10期

关键词：

acute paraprotein-induced renal failure; multiple myeloma; nephrotoxic light chains; bortezomib; hemodialysis;

D O I：

10.3324/haematol.11463

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Paraprotein induced renal failure is a frequent complication of multiple myeloma and is associated with poor survival. Previously, reversal of renal function has been hampered by the lack of fast acting and highly effective myeloma therapy and most patients remained or became dependent on hemodialysis. Here we show reversal of acute paraprotein-induced renal failure by bortezomib-based therapy in 5 out of 8 patients. Improvement of renal function was preceded by a significant reduction in paraprotein concentration in all patients, with improvement in renal function.

引用

页码：1411 / 1414

页数：4

共 20 条

[1]

Batuman V, 2007, CONTRIB NEPHROL, V153, P87

[2] Renal failure in multiple myeloma -: Presenting features and predictors of outcome in 94 patients from a single institution [J].

Bladé, J ;

Fernández-Llama, P ;

Bosch, F ;

Montoliu, J ;

Lens, XM ;

Montoto, S ;

Cases, A ;

Darnell, A ;

Rozman, C ;

Montserrat, E .

ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (17) :1889-1893

[3]

Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x

[4] Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study [J].

Chanan-Khan, Asher A. ;

Kaufman, Jonathan L. ;

Mehta, Jayesh ;

Richardson, Paul G. ;

Miller, Kena C. ;

Lonial, Sagar ;

Munshi, Nikhil C. ;

Schlossman, Robert ;

Tariman, Joseph ;

Singhal, Seema .

BLOOD, 2007, 109 (06) :2604-2606

[5] Plasma exchange when myeloma presents as acute renal failure - A randomized, controlled trial [J].

Clark, WF ;

Stewart, AK ;

Rock, GA ;

Sternbach, M ;

Sutton, DM ;

Barrett, BL ;

Heidenheim, AP ;

Garg, AX ;

Churchill, DN .

ANNALS OF INTERNAL MEDICINE, 2005, 143 (11) :777-784

[6] Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance [J].

Eleutherakis-Papaiakovou, V. ;

Bamias, A. ;

Gika, D. ;

Simeonidis, A. ;

Pouli, A. ;

Anagnostopoulos, A. ;

Michali, E. ;

Economopoulos, T. ;

Zervas, K. ;

Dimopoulos, M. A. .

LEUKEMIA & LYMPHOMA, 2007, 48 (02) :337-341

[7] Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma:: In vitro and in vivo studies [J].

Hutchison, Colin A. ;

Cockwell, Paul ;

Reid, Steven ;

Chandler, Katie ;

Mead, Graham P. ;

Harrison, John ;

Hattersley, John ;

Evans, Neil D. ;

Chappell, Mike J. ;

Cook, Mark ;

Goehl, Hermann ;

Storr, Markus ;

Bradwell, Arthur R. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (03) :886-895

[8] Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma [J].

Jagannath, S ;

Durie, BGM ;

Wolf, J ;

Camacho, E ;

Irwin, D ;

Lutzky, J ;

McKinley, M ;

Gabayan, E ;

Mazumder, A ;

Schenkein, D ;

Crowley, J .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (06) :776-783

[9] Bortezornib in recurrent and/or refractory multiple myeloma - Initial clinical experience in patients with impaired renal function [J].

Jagannath, S ;

Barlogie, B ;

Berenson, JR ;

Singhal, S ;

Alexanian, R ;

Srkalovic, G ;

Orlowski, RZ ;

Richardson, PG ;

Anderson, J ;

Nix, D ;

Esseltine, DL ;

Anderson, KC .

CANCER, 2005, 103 (06) :1195-1200

[10] TREATMENT OF RENAL-FAILURE ASSOCIATED WITH MULTIPLE-MYELOMA - PLASMAPHERESIS, HEMODIALYSIS, AND CHEMOTHERAPY [J].

JOHNSON, WJ ;

KYLE, RA ;

PINEDA, AA ;

OBRIEN, PC ;

HOLLEY, KE .

ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (04) :863-869

← 1 2 →